Clinical Trials Directory

Trials / Unknown

UnknownNCT05843682

Technological Innovation in the Virtual Assistance of Patients With Uncontrolled Arterial Hypertension - Hyper 2

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
University of Sao Paulo General Hospital · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effectiveness of the use of artificial intelligence in home monitoring in patients with uncontrolled arterial hypertension.

Detailed description

Arterial hypertension (AH) is one of the most important cardiovascular risk factors, accounting for 13.5% of all deaths worldwide. Mobile health technologies have been applied as an important tool to improve patient engagement and blood pressure (BP) control, as an alternative approach to remote monitoring of hypertensive patients. Therefore, it is essential to help patients adopt healthy measures to assist in the daily control of BP. As the barriers to therapeutic adherence are complex and varied, solutions to improve adherence at the population level should be multifactorial. Therefore, the use of an application elaborated by artificial intelligence adapted to individual needs and customs, can help in improving therapeutic adherence and provide better bp control in patients with uncontrolled hypertension.

Conditions

Interventions

TypeNameDescription
DEVICEUsing the Avatr AppThe patients will use the mobile application called Avatr, which will monitor their health data, as well as provide individualized care and early intervention through alerts generated for the multidisciplinary team.

Timeline

Start date
2022-10-07
Primary completion
2023-08-31
Completion
2024-02-29
First posted
2023-05-06
Last updated
2023-05-06

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT05843682. Inclusion in this directory is not an endorsement.